Get updated on the advances in Pharmacology and Toxicology through this Postgraduate diploma in only 6 months”

Infectious diseases and intoxications are frequent in the hospital environment, for this reason the progress in the study of antibiotics, the management through the most effective pharmacological treatments has improved patient management. In this sense, the figure of the pharmacist is key when it comes to providing the most accurate pharmacology according to the characteristics of each clinical case.

In view of this reality, the constant evolution in the pharmacological field has led professionals to continuously update their skills. Thus, this Postgraduate diploma in Pharmacology and Toxicology was created by an excellent team of experts, brought together by TECH.

It is an intensive 6-month program that is distinguished by offering students advanced content on Pharmacology in the Central Nervous System, the Gastrointestinal System and diseases, infections and intoxications. All this, from a theoretical-practical approach that will be supported by clinical case studies, video summaries of each topic, videos in detail and essential readings.

Also, thanks to the Relearning method, based on the continuous reiteration of key content, the graduates will have the opportunity to keep abreast of developments in this field, without the need to invest long hours of study and memorization.

An ideal opportunity to study a quality program in a methodology that provides the flexibility required by students to reconcile their daily activities with an academic proposal that is at the forefront.

You will be up to date on the refinement of antibiotic use in patients with skin infections”

This Postgraduate diploma in Pharmacology and Toxicology contains the most complete and up-to-date scientific program on the market. The most important features include

• The development of practical cases presented by experts in Pharmacy, Hospital Management, among others
• Graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where self-assessment can be used to improve learning
• Its special emphasis on innovative methodologies
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

The specialized literature in this program will allow you to further extend the information on the Pharmacology of the Gastrointestinal System”

The program’s teaching staff includes professionals from sector who contribute their work experience to this educational program, as well as renowned specialists from leading societies and prestigious universities.

Its multimedia content, developed with the latest educational technology, will provide the professionals with situated and contextual learning, i.e., a simulated environment that will provide an immersive education programmed to learn in real situations.

The design of this program focuses on Problem-Based Learning, by means of which the professionals must try to solve the different professional practice situations that are presented throughout the academic course. For this purpose, the students will be assisted by an innovative interactive video system created by renowned experts.

Thanks to this qualification you will be up to date with the pharmacology used to treat substance abuse disorders"

Update yourself at your own pace and from the comfort of your home with TECH's 100% online methodology"

Thanks to the multimedia didactic material and the numerous additional tools, the graduates who enters this university program will be able to update their knowledge in an effective and dynamic way. Thus, they will go through the 3 modules that make up this university program and will deepen in the Pharmacology used to address pathologies of the Central Nervous System, the Gastrointestinal System and the one used for infectious diseases and intoxications. All this, in addition, from a virtual library, accessible 24 hours a day, from any digital device with Internet connection.

Extend even further the information provided in this program thanks to the scientific literature you will find in the virtual library”

Module 1. Pharmacology of the Central Nervous System

1.1. Ischemic Strokes

1.1.1. Advances in the early diagnosis of ischemic stroke
1.1.2. Evaluation and classification of the risk of ischemic stroke in asymptomatic patients
1.1.3. Thrombolytic treatment strategies in the acute phase of ischemic stroke
1.1.4. Biomarkers in Ischemic Stroke

1.2. Management of hypertension in acute ischemic stroke

1.2.1. Current guidelines and protocols for the management of hypertension in acute ischemic stroke
1.2.2. Pharmacologic treatment of hypertension in the acute phase of ischemic stroke
1.2.3. Blood pressure control strategies in ischemic stroke with thrombolytic therapy
1.2.4. Endovascular therapy and blood pressure control in acute ischemic stroke

1.3. Oropharyngeal angioedema due to Alteplase

1.3.1. Risk factors for the development of oropharyngeal angioedema after Alteplase administration
1.3.2. Clinical and differential diagnosis of oropharyngeal angioedema in patients treated with Aateplase
1.3.3. Management and treatment of acute oropharyngeal angioedema by Alteplase
1.3.4. Evaluation and follow-up of patients with a history of oropharyngeal angioedema prior to administration of Alteplase

1.4. Hemorrhagic stroke: intracerebral hemorrhage (ICH)

1.4.1. Diagnosis and classification of intracerebral hemorrhage in hemorrhagic stroke
1.4.2. Medical and pharmacological treatment of acute intracerebral hemorrhage
1.4.3. Neurosurgical and endovascular management of intracerebral hemorrhage
1.4.4. Multidisciplinary approach in the care of the patient with intracerebral hemorrhage

1.5. Cerebral edema

1.5.1. Cytotoxic versus vasogenic cerebral edema
1.5.2. Clinical evaluation and imaging of cerebral edema
1.5.3. Pharmacological strategies for the reduction of cerebral edema in specific pathologies
1.5.4. Effect of cerebral edema

1.6. Opioid overdose

1.6.1. Pharmacokinetics and pharmacodynamics of opioids involved in overdose
1.6.2. Role of the hospital pharmacist in opioid overdose prevention and education
1.6.3. Management of opioid withdrawal in the hospital setting
1.6.4. Naloxone and its use as an antidote in opioid overdose reversal

1.7. Opioid Withdrawal Syndrome

1.7.1. Epidemiology and risk factors for the development of Opioid Withdrawal Syndrome
1.7.2. Clinical evaluation and diagnosis of Opioid Withdrawal Syndrome in hospitalized patients
1.7.3. Pharmacological management of Opioid Withdrawal Syndrome in the hospital setting
1.7.4. Use of opioid agonist and antagonist drugs in the treatment of withdrawal syndrome

1.8. Agitated Patient Management

1.8.1. Epidemiology and risk factors associated with agitation in hospitalized patients
1.8.2. Pharmacotherapy for the management of acute agitation in inpatients
1.8.3. Use of antipsychotics and benzodiazepines in the treatment of agitation
1.8.4. Safety and prevention of complications in the management of the agitated patient

1.9. Acute pain management in the patient with substance abuse

1.9.1. Pharmacological interactions between analgesics and substances of abuse
1.9.2. Pharmacological strategies for acute pain management in patients with opioid abuse
1.9.3. Acute pain Treatment in patient with Alcohol abuse
1.9.4. Assessment and management of addiction risk in patients with substance abuse requiring analgesia

1.10. Alcohol Withdrawal Syndrome

1.10.1. Clinical evaluation and diagnosis of Alcohol Withdrawal Syndrome in hospitalized patients
1.10.2. Pharmacotherapy for the management of Alcohol Withdrawal Syndrome in the inpatient setting
1.10.3. Use of benzodiazepines and other drugs in the treatment of Alcohol Withdrawal Syndrome
1.10.4. Role of the hospital pharmacist in the management of Alcohol Withdrawal Syndrome

Module 2. Pharmacology of the Gastrointestinal System

2.1. Chronic Hepatic Disease

2.1.1. Diagnosis and classification of chronic liver diseases
2.1.2. Biomarkers and liver function tests in diagnosis and follow-up
2.1.3. Strategies for management and prevention of disease progression
2.1.4. Pharmacological treatment of chronic liver disease

2.2. Upper gastrointestinal bleeding (UGH)

2.2.1. Epidemiology and risk factors associated to Upper Gastrointestinal Bleeding
2.2.2. Classification and Etiology of Upper Gastrointestinal Bleeding
2.2.3. Diagnosis and early detection methods of HDA
2.2.4. Pharmacological Treatment of HDA

2.3. Spontaneous Bacterial Peritonitis (SBP)

2.3.1. Anatomy and physiology of the peritoneum and its relationship with PBE
2.3.2. Clinical diagnosis and methods of detection of spontaneous bacterial peritonitis
2.3.3. Evaluation and classification of patients with SBP
2.3.4. Pharmacological treatment of spontaneous bacterial peritonitis

2.4. Hydroelectrolytic Alterations

2.4.1. Sodium
2.4.2. Chlorine
2.4.3. Potassium
2.4.4. Phosphorus

2.5. Clostridium difficile infection (CDI)

2.5.1. Epidemiology and risk factors associated to CDI
2.5.2. CDI Diagnosis
2.5.3. Clinical evaluation of the patient with Clostridium difficile infection
2.5.4. Pharmacological Treatment of CDI

2.6. Complicated intra-abdominal infection (CAIbc)

2.6.1. Epidemiology and risk factors associated to complicated intra-abdominal infection
2.6.2. Etiology and pathogenesis of cCBI
2.6.3. Clinical evaluation of the patient with cBAI
2.6.4. Pharmacological treatment of complicated intra-abdominal infection

2.7. Pancreatitis

2.7.1. Epidemiology and risk factors associated to Pancreatitis
2.7.2. Etiology and Classification of Pancreatitis
2.7.3. Clinical diagnosis and methods of detection of Pancreatitis
2.7.4. Pharmacological treatment of acute and chronic pancreatitis

2.8. Irritable Bowel Syndrome

2.8.1. Anatomy and physiology of the gastrointestinal system related to irritable bowel syndrome
2.8.2. Etiology and pathogenesis of irritable bowel syndrome
2.8.3. Classification and subtypes of IBS
2.8.4. Medical treatment of irritable bowel syndrome

2.9. Pharmacology of Mucolytics and Expectorants in Respiratory Diseases

2.9.1. Anatomy and physiology of the gastrointestinal system and the control of motility
2.9.2. Classification and mechanisms of action of prokinetics and antiemetics
2.9.3. Indications and contraindications for the use of prokinetics and antiemetics
2.9.4. Pharmacological treatment of nausea and vomiting induced by opioids and other drugs

2.10. Pharmacology of drugs used in nutritional therapy

2.10.1. Classification and Types of nutritional therapy
2.10.2. Administration of drugs and enteral nutrition: interactions and special considerations
2.10.3. Medications used for the management of malnutrition and nutritional support in critically ill patients
2.10.4. Antibiotics and antifungals in enteral and parenteral nutrition patients

Module 3. Pharmacology of infectious diseases and intoxications

3.1. Responsible Antibiotic Use

3.1.1. Classification
3.1.2. Mechanisms of action
3.1.3. Spectrum of activity
3.1.4. Principles of antibiotic pharmacokinetics and pharmacodynamics

3.2. Urinary Tract Infections(ITU)

3.2.1. Anatomy and physiology of the urinary tract related to urinary tract infection
3.2.2. Etiology and pathogenesis of cCBI
3.2.3. Classification of Urinary Tract Infection
3.2.4. Pharmacologic treatment of urinary tract infection

3.3. Skin and soft tissue infection (STEMI)

3.3.1. Anatomy and physiology of skin and soft tissues related to IPPB
3.3.2. Classification and Types of Skin and Soft Tissue Infections
3.3.3. Evaluation of the patient with IPPB in the hospital setting
3.3.4. Pharmacologic treatment of Skin and Soft Tissue Infections

3.4. Pneumonia

3.4.1. Anatomy and physiology of the Respiratory System relationship with Pneumonia
3.4.2. Etiology and pathogenesis of pneumonia
3.4.3. Classification of pneumonia according to etiology and severity
3.4.4. Pharmacological Treatment of Pneumonia

3.5. Meningitis

3.5.1. Anatomy and physiology of the central nervous system relationship with Meningitis
3.5.2. Classification of meningitis according to the causative agent and the clinical presentation
3.5.3. Evaluation and classification of the patient with meningitis
3.5.4. Pharmacological Treatment of Meningitis

3.6. Sepsis

3.6.1. Anatomy and physiology of the Immune function System relationship with Sepsis
3.6.2. Etiology and pathogenesis of Sepsis
3.6.3. Classification and Stages of Sepsis
6.6.4. Pharmacological Treatment of Sepsis

3.7. Acute psychosis and delirium

3.7.1. Etiology and pathogenesis of acute psychosis and delirium
3.7.2. Classification and subtypes of acute psychosis delirium
3.7.3. Assessment and classification of the patient with acute psychosis and delirium in the hospital setting
3.7.4. Pharmacological treatment of acute psychosis and delirium

3.8. Acetylsalicylic acid (ASA) intoxication

3.8.1. Toxicokinetics of acetylsalicylic acid in intoxication
3.8.2. Toxic effects and clinical symptoms associated with acetylsalicylic acid poisoning
3.8.3. Clinical diagnosis and methods of detection of AAS poisoning
3.8.4. Treatment and pharmacotherapeutic management of ASA poisoning

3.9. Pathophysiology of Epilepsy

3.9.1. Toxicokinetics of Paracetamol in poisoning
3.9.2. Toxic effects and clinical symptoms associated with Paracetamol poisoning
3.9.3. Clinical diagnosis and methods of detection of Paracetamol poisoning
3.9.4. Treatment and pharmacotherapeutic management of ASA poisoning

3.10. Antidotes

3.10.1. General principles of poisoning management in the hospital setting
3.10.2. Identification and diagnosis of poisonings and intoxications
3.10.3. Pharmacotherapeutic management of poisonings
3.10.4. Use and administration of antidotes in specific poisonings

It delves with the best didactic material in the most current Pharmacology used to treat Meningitis, Pneumonia or Skin Infection”